'Poorly designed': ICMR on BHU Covaxin safety study

The Indian Council of Medical Research Director General Dr Rajiv Bahl on Monday criticised a recently published study on the long-term safety analysis of the Covaxin in adults and adolescents for......

Covaxin effective against Delta Plus: ICMR study

Bharat Biotech's COVID-19 vaccine Covaxin (BBV152) is effective against Delta Plus (AY.1) variant of the coronavirus, according to a study by the Indian Council of Medical and Research. IMAGE:......

Covaxin: No serious adverse events in phase 1 trials

The interim findings of phase 1 clinical trial of COVID-19 vaccine Covaxin, indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research, showed that it was......

Covaxin 50% effective against symptomatic Covid: Lancet

Two doses of Covaxin are 50 per cent effective against symptomatic disease, according to the first real-world assessment of India's indigenous COVID-19 vaccine published in The Lancet Infectious......